Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

77
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
77
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Analysis of Clinical and Patient-Reported Outcomes of a New Enhanced Monofocal IOL and a Conventional Monofocal IOL.

Clinical ophthalmology (Auckland, N.Z.)·2024
Same author

Intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction: A randomized controlled study.

PloS one·2022
Same author

Evaluation of Visual and Subjective Outcomes with Mix-and-Match of Three One-Piece Tecnis Multifocal IOLs of Varying Add Powers.

Clinical ophthalmology (Auckland, N.Z.)·2020
Same author

Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction.

Clinical ophthalmology (Auckland, N.Z.)·2017
Same author

August consultation #3.

Journal of cataract and refractive surgery·2016
Same author

What's wrong with Dr. Oz?

Missouri medicine·2015

Related Experiment Video

Updated: Feb 25, 2026

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
05:00

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Published on: April 1, 2019

15.7K

Intense pulsed light for evaporative dry eye disease.

Steven J Dell1

  • 1Dell Laser Consultants, Austin, TX, USA.

Clinical Ophthalmology (Auckland, N.Z.)
|August 10, 2017
PubMed
Summary
This summary is machine-generated.

Intense pulsed light (IPL) therapy may improve dry eye disease (DED) and meibomian gland dysfunction (MGD) by reducing inflammation. This review explores the potential mechanisms behind IPL

Keywords:
dry eye diseaseintense pulsed lightmeibomian gland dysfunctionskin rosacea

More Related Videos

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

779
Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
04:43

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

909

Related Experiment Videos

Last Updated: Feb 25, 2026

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
05:00

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Published on: April 1, 2019

15.7K
Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

779
Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
04:43

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

909

Area of Science:

  • Ophthalmology and Dermatology
  • Medical technology

Background:

  • Dry eye disease (DED) is frequently associated with periocular inflammatory skin conditions like rosacea.
  • Intense pulsed light (IPL) is an established treatment for facial rosacea.

Purpose of the Study:

  • To review and discuss the potential mechanisms of action for Intense Pulsed Light (IPL) therapy in treating dry eye disease (DED) and meibomian gland dysfunction (MGD).

Main Methods:

  • Literature review of existing studies on IPL therapy for rosacea, DED, and MGD.
  • Analysis of proposed biological and physical mechanisms underlying IPL's effects.

Main Results:

  • IPL treatment has shown efficacy in reducing DED signs and symptoms in patients with MGD.
  • Several plausible mechanisms, including anti-inflammatory effects and improved meibomian gland function, are proposed for IPL's therapeutic action in DED/MGD.

Conclusions:

  • IPL therapy presents a promising treatment modality for DED and MGD, potentially through modulating inflammation and enhancing ocular surface health.
  • Further research is warranted to elucidate the precise mechanisms of IPL in the context of DED and MGD.